English | Español
Patient Daily | Oct 6, 2021

COVID-19 patients, families launch petition to convince FDA to approve promising drug

Press release submission | Oct 2, 2021

Alzinova receives approval to start the first clinical study with the oligomer-specific ALZ-101 vaccine in patients with Alzheimer's disease

Press release submission | Oct 1, 2021

CNS Pharmaceuticals Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM)
Bree Gonzales | Sep 27, 2021

Decision on Maine’s COVID-19 vaccine mandate will determine if it 'violates the First Amendment'
Bree Gonzales | Sep 27, 2021

Congressional Democrats to provide health insurance because Mississippi has 'refused to expand' Medicaid
Press release submission | Sep 26, 2021

Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients
Press release submission | Sep 25, 2021

New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
Press release submission | Sep 24, 2021

Merck Manuals Shares Details to Help Patients Navigate the Controversies of Prostate Cancer Screenings

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments